Synthesis and properties of 3′-azido-3′-deoxythymidine derivatives of glycerolipids

Pharmaceutical Chemistry Journal

Volumn 44, Issue 10, 2011, Pages 557-563

  Lonshakov, D V ^a   Baranova, E O ^a   Lyutik, A I ^a   Shastina, N S ^a   Shvets, V I ^a  

^a MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

Author keywords

3 azido 3 deoxythymidine; bioavailability; glycerides; liponucleosides; prodrugs

Indexed keywords

1 (3' AZIDO 3' DEOXYTHYMIDINE 5' O PHOSPHO)OXY 6 (1,3 DIPALMITOYLGLYCERO 2 O SUCCINYL)OXYHEXANE; 1 (3' AZIDO 3' DEOXYTHYMIDINE 5' O SUCCINYL)OXY 12 (1,3 DIPALMITOYLGLYCERO 2 O SUCCINYL)OXYDODECANE; DIACYLGLYCEROL DERIVATIVE; LIPOSOME; PRODRUG; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; DRUG HYDROLYSIS; DRUG SYNTHESIS; HYDROPHOBICITY; LIPOSOMAL DELIVERY; PHARMACOPHORE;

EID: 79953210319     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-011-0517-y     Document Type: Article

References (23)

1. E. Clercq, J. Clin. Virol., 30, 115-133 (2004).
2. R. F. Schinazi, B. I. Hernandez-Santiago, and S. J. Hurwitz, Antiviral Res., 71, 322-334 (2006).
3. E. Clercq, Antiviral Res., 67, 56-75 (2005).
4. W. N. Charman and C. J. H. Porter, Adv. Drug. Delivery Rev., 19, 149-169 (1996).
5. D. M. Lambert, Eur. J. Pharm. Sci., 11(2), S15-S27 (2000).
6. A. Wong and I. Toth, Curr. Med. Chem., 8(9), 1123-1136 (2001).
7. N. L. Trevaskis,W. N. Charman, and C. J. H. Porter, Adv. Drug. Delivery Res., 60, 702-716 (2008).
8. G. K. E. Scriba, Arch. Pharm. (Weinheim, Ger.), 326, 477-481 (1993).
9. M. Lalanne, A. Paci, K. Andrieux, et al., Bioorg. Med. Chem., 17, 2237-2240 (2007).
10. R. L. Mackman and T. Cihlar, Annu. Rep. Med. Chem., 39, 305-321 (2004).
11. T. Kamijo, H. Harada, and K. Iizuka, Chem. Pharm. Bull., 32, 5044-5047 (1984).
12. F. Bonina, C. Puglia, M. G. Rimoli, et al., Eur. J. Pharm. Sci., 16, 167-174 (2002).
13. A. Yu. Zamyatina, A. S. Bushnev, and V. I. Shvets, Bioorg. Khim., 20(12), 1253-1296 (1994).
14. I. Lindh and J. Stawinski, J. Org. Chem., 54(6), 1338-1342 (1989).
15. O. A. Tuchnaya, O. V. Gorlachuk, V. A. Livshits, et al., Khim.-farm. Zh., 42(1), 6-12 (2008).
16. N. S. Shastina, O. A. Tuchnaya, L. I. Einisman, et al., Bioorg. Khim., 29(3), 296-302 (2003).
17. O. A. Tuchnaya, S. N. Elizarova, S. A. Sharikova, et al., Khim.-farm. Zh., 40(5), 41-45 (2006).
18. G. K. E. Scriba, Arch. Pharm. (Weinheim, Ger.), 327, 347-348 (1994).
19. G. K. E. Scriba, Pharm. Res., 10(8), 1181-1186 (1993).
20. K. Y. Hostetler, L. M. Stuhmiller, H. B. M. Lenting, et al., J. Biol. Chem., 265(11), 6112-6117 (1990).
21. A. S. Dudnichenko, Yu. M. Krasnopol'skii, and V. I. Shvets, Liposomal Drugs in Experiment and the Clinic [in Russian], RA-Karavella, Kharkov (2001).
22. S. K. Sahoo, F. Dilnawaz, and S. Krishnakumar, Drug Discovery Today, 13(3-4), 144-151 (2008).
23. E. Ojewole, I. Mackraj, P. Naidoo, and T. Govender, Eur. J. Pharm. Biopharm., 70, 697-710 (2008).